Loading

Plasma Urate and Neurodegenerative Disease

Review Article | Open Access | Volume 8 | Issue 1

  • 1. Department of Animal and Nutritional Sciences, West Virginia University, Morgantown, WV, USA
+ Show More - Show Less
Corresponding Authors
Hillar Klandorf, Department of Animal and Nutritional Sciences, P.O. Box 6108, West Virginia University, Morgantown, WV, USA Tel: 304 293-1897; FAX: 304 293-2232
Abstract

Diminished levels of urate have been linked to oxidative stress in birds and mammals. Urate, a major antioxidant that lowers reactive oxygen/nitrogen species (ROS/RNS), ameliorates these effects. Recent studies have proposed that an increased permeability in the intestine due to some insult can induce inflammation in peripheral organs such as the brain. Allopurinol, a relatively toxic purine analogue that serves as a xanthine oxidase inhibitor, reduces urate levels which can subsequently induce an inflammation state in the intestine. Recent studies have implicated that the intestinal permeability can be with linked with CNS dysfunction, which include Parkinson’s, Alzheimer’s, autism, schizophrenia, multiple sclerosis, depression, anxiety, and post-traumatic stress disorder. However, the relationship between reduced urate, the immune system and the pathogenesis of the intestine, the liver or the brain has not been well characterized in avians. The elevated body temperatures of birds may accentuate the pathogenesis of complications induced by allopurinol and so may be a model for future studies investigating neurodegenerative disease progression

Keywords

•    Allopurinol
•    Il-6
•    TNF-alpha
•    Brain inflammation
•    Gut inflammation

Citation

Marku L, Klandorf H (2021) Plasma Urate and Neurodegenerative Disease. J Drug Des Res 8(1): 1078.

INTRODUCTION

Urate is synthesized the liver, intestines and the vascular endothelium as a product of an exogenous pool of purines [1]. Urate can also be produced endogenously by damaged, dying or dead cells; where nucleic acids, adenine, and guanine, are degraded into urate to act as damage-associated molecular patterns [1], [2]. This biomolecule conventionally generates concerns due to acute and chronic inflammatory arthritis, gout, and other metabolic diseases [1], [3]. However, it is also thought to have a dual role and serve by inducing a type 2 immune response [1], [2], [4]. The inhibition of urate production can elucidate the protective potential by observing how lowered urate concentrations alter immunological function in several organs [5], [6]. Several studies have indicated how the intestinal environment can exert profound effects on the liver and central nervous system through the regulation of the microbiota and the intestinal barrier function [7]. This gut-brain connection is becoming a model of immune activity with a fundamental contribution towards neurodegenerative disorders [7]. These studies indicate that inflammation in the intestine appears to be particularly relevant in the disease pathogenesis. Studies have shown that urate serves as a potent scavenger of singlet oxygen, peroxyl radicals and hydroxyl radicals [6]. Elevated urate concentrations in the circulation helps to protect cells by scavenging these free radicals which then prolongs the organism’s life [6], [8]. Living systems have adapted to regulate free radicals by developing pathways to inactivate these reactive species such as oxygen and nitrogen, which induce tissue injury [6], [9]. Allopurinol, a toxic purine analog, serves as a xanthine oxidase inhibitor which reduces urate concentrations; which can induce a type I inflammation state in the intestine and brain of birds [3]. Changes in the compositions of the bacterial populations in the intestines have also been widely associated with an array of conditions that can cause neurological and developmental disorders such as multiple sclerosis, autism, depression, schizophrenia, and Parkinson’s disease [4], [7]. Shifts in intestinal microbiota can alter concentrations of growth factors and signaling proteins in the brain, which contributes to inflammation and functional changes in the neurological remodeling [5]. Among the roles for gut bacteria are the conversion of primary bile acids produced by the liver to secondary bile acids which then are absorbed through the intestinal epithelium [7]. Moreover, bile acids can also act as potent signaling molecules that regulate a variety of processes related to both the nervous and immune systems. A detailed look into the effects of allopurinol on the early recognition and effector response by the immune system in the intestines could elucidate how these responses affect the liver and brain [4], [7]. Metabolites generated from intestinal microbes such as those described here have also been reported to alter host gene expression in the brain, providing ways for the microbiota to influence the activity of the CNS [4], [7]. Thus, the administration of allopurinol can potentially evoke strong type 1 immune reactions via IL-6 by altering the intestinal environment and induce effects that ultimately alter CNS function.

The Immune System and The Urate Paradox

A vast amount literature shows an elevated level of urate is strongly associated with inflammatory diseases such as hypertension, cardiovascular and cerebrovascular events [2], [3], [10]. While urate accounts for over half of the free radical scavenging activity in blood [8], it can also reduce the oxidative stress implicated in several neurodegenerative diseases. Antioxidant activities of urate can quench superoxide and singlet oxygen and protecting oxidation of vitamin C through the chelation of iron [6], [11]. These qualities make urate an attractive CNS antioxidant because neurons are remarkably susceptible to oxidative stress. In multiple sclerosis, free radicals can contribute to the inflammation and demyelination of axons [10], [12]. Thus, preventing oxidative damage may delay onset and improve the prognosis of CNS disorders [10]. The ratio of reactive species over antioxidants determine the shift from their advantageous function to detrimental effects [11]. The major source of these reactive species that become detrimental are dependent on cell type, duration of oxidant production, reactive species produced, and the localization of their source [6]. The oxidant-antioxidant paradox can be further investigated by the analyzing how decreased blood urate can alter various genes associated with inflammation [4], [6], [10].

Urate’s Systemic Effects

Immune cells can engage in direct communication with these dying cells as well as with neurons. The extent of the functional impact of neuroimmune synapses is not known. However, activated immune cells can modulate neuronal activity via neurotransmitters and cytokines [4]. Proinflammatory cytokines and activated immune cells in the circulation also access the brain when the blood brain barrier is compromised [2]. Systemic inflammation associated with increased BBB permeability can be considered a precursor to neurodegenerative diseases [13]. Extensive evidence has reported linking molecules associated with inflammatory conditions, which include cytokines, reactive oxygen species, matrix metalloproteases, and mediators of angiogenesis with blood brain barrier disruption [2], [13]. Additionally, a positive feedback loop involving IL-6 in conjunction with neuroimmune reflex circuits has been implicated in increasing permeability such that peripheral T cells gain access to the CNS [7]. Leaks in the blood brain barrier can significantly alter immune responses to CNS antigens and compromise CNS protection against potentially harmful substances [7], [13].

The systemic effects of intestinal inflammation may be further augmented by increases in intestinal permeability via some insult to the gut [7]. Acute tissue injury may occur with a severe infection generated by an intestinal pathogen, which causes temporary defects in the intestinal epithelial barrier [2]. These low-grade insults induce more selective increases in paracellular permeability through regulation of tight junctions. Intestinal microbes also regulate expression of barrier promoting tight junction proteins [7]. While many proinflammatory cytokines secreted by activated immune cells, which include TNF, IL-1β, and IL-6, allow for tight junctions to increase barrier permeability in order to facilitate recruitment of immune cells and other molecules [2], [14], [15], [16], [17], [18]. However, a side effect of this response permits microbes to leak from the intestine into the peritoneal cavity and from there into the blood, which then triggers a systemic proinflammatory immune responses [7].

Typically, the immune challenge is rapidly cleared, proinflammatory responses terminate, and gut barrier function is restored [7]. However, unique features of the intestine allow for persistent inflammation and barrier dysfunction [7]. Sustained permeability of the intestinal barrier can have harmful effects on numerous body systems. Many microbial components can trigger “leaky gut syndrome” and lead to conditions like Irritable bowel syndrome (IBS) and metabolic syndrome. Moreover, recent studies have implicated that intestinal permeability can be with linked with CNS dysfunction, which include Parkinson’s, Alzheimer’s, autism, schizophrenia, multiple sclerosis, depression, anxiety, and post-traumatic stress disorder [7]. Proinflammatory responses in the brain can alter CNS function and CNS immune responses can have serious and enduring consequences. If inflammation becomes chronic, proinflammatory cytokines and oxidative stress that are linked to neuron death, and neuroinflammation should be investigated as a key factor in numerous neurodegenerative diseases.

DISCUSSION & CONCLUSION

Typically, the immune challenge is rapidly cleared, proinflammatory responses terminate, and gut barrier function is restored [7]. However, unique features of the intestine allow for persistent inflammation and barrier dysfunction [7]. Sustained permeability of the intestinal barrier can have harmful effects on numerous body systems. Many microbial components can trigger “leaky gut syndrome” and lead to conditions like Irritable bowel syndrome (IBS) and metabolic syndrome. Moreover, recent studies have implicated that intestinal permeability can be with linked with CNS dysfunction, which include Parkinson’s, Alzheimer’s, autism, schizophrenia, multiple sclerosis, depression, anxiety, and post-traumatic stress disorder [7]. Proinflammatory responses in the brain can alter CNS function and CNS immune responses can have serious and enduring consequences. If inflammation becomes chronic, proinflammatory cytokines and oxidative stress that are linked to neuron death, and neuroinflammation should be investigated as a key factor in numerous neurodegenerative diseases. Further, the elevated body temperatures of birds may accentuate the pathogenesis of complications induced by allopurinol and so may be a model for future studies investigating neurodegenerative disease progression.

REFERENCES

1. Bowman Gene L, et al. Uric Acid as a CNS Antioxidant. J Alzheimers Dis. 2010; 19: 1331:1336.

2. Chen Juxing, et al. Identification of Potential Biomarkers for Gut Barrier Failure in Broiler Chickens. Front Vet Sci. 2015; 2: 14.

3. Elion Gertrude B. Allopurinol and Other Inhibitors of Urate Synthesis. Springer, Berlin, Heidelberg. 1978.

4. Fang Pu, et al. A Double-Edged Sword: Uric Acid and Neurological Disorders. Brain Disord Ther. 2013; 2: 109.

5. George Jacob, et al. High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid. Circulation. 2006; 114: 2508-2516.

6. Gersch, et al. Uric Acid and the Immune Response. Nephrol. Dial. Transplant. 2006; 21: 3046-3047.

7. Ghaemi-Oskouie, Faranak, and Yan Shi. The Role of Uric Acid as an Endogenous Danger Signal in Immunity and Inflammation. Curr Rheumatol Rep. 2011; 13: 160-166.

8. Heo, Sung Hyuk, and Seung-Hoon Lee. High Levels of Serum Uric Acid Are Associated with Silent Brain Infarction. J Neurol Sci .2010; 297: 6-10.

9. Hong, Yeong Ho, et al. Analysis of Chicken Cytokine and Chemokine Gene Expression Following Eimeria Acervulina and Eimeria Tenella Infections. Vet Immunol Immunopathol. 2006; 114: 209-223.

10. Hong, Yeong Ho, et al. Changes in Immune-Related Gene Expression and Intestinal Lymphocyte Subpopulations Following Eimeria Maxima Infection of Chickens. Vet Immunol Immunopathol. 2006; 114: 259-272.

11. Houser, Madelyn C., and Malú G. Tansey. “The Gut-Brain Axis: Is Intestinal Inflammation a Silent Driver of Parkinson’s Disease Pathogenesis. Parkinson’s Disease. 2017.

12. Keith W. Jarosinski Bradley L. Njaa Priscilla H. O’connellDr, et al. “Pro-Inflammatory Responses in Chicken Spleen and Brain Tissues after Infection with Very Virulent Plus Marek’s Disease Virus.” Mary Ann Liebert. 2005.

13. Martinon, Fabio. Update on Biology: Uric Acid and the Activation of Immune and Inflammatory Cells. Curr Rheumatol Rep. 2010; 12: 135- 141.

14. Neuman, Manuela G, et al. Biomarkers in Nonalcoholic Fatty Liver Disease. Can J Gastroenterol Hepatol. 2014; 28: 607-618.

15. Yu, Min-A; Sánchez-Lozada, Laura G; Johnson, Richard J; Kang, Duk-Hee. “Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 2010; 28: 1234-1242.

16. Pathology of Pet and Aviary Birds.Wiley Online Library. 2003.

17. Sautin, Yuri Y, and Richard J Johnson. Uric Acid: the Oxidant-Antioxidant Paradox. Nucleosides Nucleotides Nucleic Acids. 2008; 27: 608-619.

18. Shi, Yan. Caught Red-Handed: Uric Acid Is an Agent of Inflammation. J Clin Invest. 2010; 120: 1809-1811.

Marku L, Klandorf H (2021) Plasma Urate and Neurodegenerative Disease. J Drug Des Res 8(1): 1078.

Received : 04 Feb 2021
Accepted : 05 Mar 2021
Published : 07 Mar 2021
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X